메뉴 건너뛰기




Volumn 42, Issue 2-3, 2000, Pages 119-129

Allogeneic bone marrow tranplantation for young adult patients with newly diagnosed acute myeloid leukemia: HLA-matched sibling donor availability does not improve treatment outcome

Author keywords

Acute myeloid leukemia; Allogenic transplantation; Chemotherapy; Prognosis

Indexed keywords

AMSACRINE; ANTINEOPLASTIC AGENT; CYCLOSPORIN A; CYTARABINE; DAUNORUBICIN; ETOPOFOS; IDARUBICIN; METHOTREXATE; MITOXANTRONE; TIOGUANINE;

EID: 0033635660     PISSN: 12693286     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00282-000-0119-8     Document Type: Article
Times cited : (1)

References (56)
  • 28
    • 0004643403 scopus 로고
    • New IBMTR/ABMTR slides summarize current use and outcome of allogeneic and autologous transplants
    • (1995) IBMTR Newsletter , vol.2 , pp. 2-8
    • Horowitz, M.M.1
  • 40
    • 0024247720 scopus 로고
    • Allogeneic transplantation versus intensive chemotherapy in first remission acute leukemia: Is there a 'best choice'?
    • (1988) J Clin Oncol , vol.6 , pp. 1532-1536
    • Mayer, R.J.1
  • 51
    • 0025757033 scopus 로고
    • The value of BMT in AML patients in first remission. A statistician's view-point
    • (1991) Ann Hematol , vol.62 , pp. 41-44
    • Suciu, S.1
  • 54
    • 0002451685 scopus 로고
    • WHO offset publication: 48 WHO-Geneva
    • (1979)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.